company info　｜　Genome Pharmaceuticals Institute

Name	Genome Pharmaceuticals Institute Co., Ltd.
Founded	Dec. 21, 2000
Capital	36,373,095 yen
Our Business	Purpose A bio-venture company of cooperation between industry and academia. And that is established to rely on research of Professor Sekimizu of University of Tokyo to put into practical use. Area 1．To develop antibiotics 2．To develop functional health foods using innate stimulant index, and its entrusted business 3．To develop disease models using silkworm, and its entrusted business
Place *head office	1-27-8-1207 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
*lab. & office	Office: 102 Next Building, 3-24-17 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan Tel: +81 3 5684 8570 Lab: 201B The University of Tokyo Kashiwa Venture Plaza, 5-4-19, Kashiwanoha, Kashiwa, Chiba 277-0882, Japan Tel: +81 4 7128 8066

2000	December	Founded as limited company
2001	April	Started business with Japanese major pharmaceutical company based on collaborative research agreement
2005	March	Capitalized by NIF ventures Co., Ltd.
	May	Opened Wet Lab. at sotokanda, chiyoda-ku, Tokyo
	May	Reorganized and incorporated. Company name changed to Genome Pharmaceuticals Institute Co., Ltd.
2007	July	Joined to the basic research by National Institute of Biomedical Innovation as an implementation institute （研究プロジェクト名：カイコ幼虫感染症モデルを用いた、バイオアッセイによる感染症治療薬シーズの開発）
	August	Moved to University of Tokyo Entrepreneur Plaza, Hongo, Bunkyo-ku, Tokyo
2008	July	Our theme was selected for “Practical Application of the Results of Innovative Research by Universities and other Institutions” by Japan Science and Technology Agency (JST) 研究課題名：カイコをテスターとする、農産物、食品、並びに環境の毒性・病原性試験法の開発